Patient Management

2074 soru

Soru 2041Soru →

An asymptomatic 68-year-old woman is seen in the outpatient clinic for a health maintenance examination. Her medical history includes well-controlled primary hypertension and mild osteoarthritis of the knees. The patient reports smoking one pack of cigarettes daily from age 20 until she quit on her 60th birthday. Her last screening colonoscopy was performed at age 62 and revealed no polyps or abnormalities. A mammogram was obtained 6 months ago with benign findings. Bone densitometry at age 65 showed normal bone mineral density. Current medications include amlodipine and as-needed ibuprofen. Vital signs are within normal limits, and the physical examination shows no significant findings. Which of the following is the most appropriate next step in preventive screening for this patient?

Cevabı ve açıklamayı göster

Cevap: Low-dose computed tomography of the chest

Cevap

The most appropriate next step is low-dose computed tomography of the chest.
This patient is 68 years old and has a 40 pack-year smoking history, having quit 8 years ago. According to the United States Preventive Services Task Force (USPSTF), annual screening for lung cancer with low-dose computed tomography of the chest is recommended for adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Because she meets all criteria and has not received this screening, it is a Grade B recommendation and the most appropriate next step in her preventive care.

Adım Adım Çözüm

1
Evaluate the patient's age and smoking history to determine lung cancer screening eligibility.
The patient is 68 years old, has a 40 pack-year smoking history, and quit 8 years ago.
Lung cancer screening criteria require age 50-80, at least a 20 pack-year history, and having smoked within the past 15 years.
2
Assess the patient's eligibility for other age-appropriate preventive screenings based on her clinical history.
She is up to date on colorectal screening (colonoscopy 6 years ago), breast cancer screening (mammogram 6 months ago), and osteoporosis screening (normal DEXA at age 65).
To rule out other recommended screenings that might be due at this visit.
3
Determine the applicability of abdominal aortic aneurysm (AAA) screening given her smoking history.
AAA screening is not routinely recommended for women.
The USPSTF recommends AAA screening for men aged 65-75 with any smoking history, but evidence is insufficient for women.

Anahtar Kavram

USPSTF guidelines for lung cancer and abdominal aortic aneurysm (AAA) screening in older adults with a significant smoking history.
Tahmini Süre:1m 0s
Soru 2042Soru →

A 72-year-old male presents to the clinic for a routine wellness evaluation. He has a medical history of essential hypertension that is well controlled with amlodipine. He feels well and reports no weight loss, changes in bowel habits, or urinary symptoms. He is a retired teacher who has never smoked and consumes alcohol occasionally. There is no family history of cancer. A review of his electronic medical record shows that his last preventive colonoscopy was performed 10 years ago and was normal. During the visit, the patient asks if he should be tested for prostate cancer, noting that a friend of the same age recently had a prostate-specific antigen (PSA) blood test. Which of the following is the most appropriate next step in managing this patient's preventive care?

Cevabı ve açıklamayı göster

Cevap: Schedule a screening colonoscopy and advise against PSA testing

Cevap

Schedule a screening colonoscopy and advise against PSA testing
The correct decision schedules a colonoscopy and advises against PSA testing. The United States Preventive Services Task Force (USPSTF) recommends routine screening for colorectal cancer in all average-risk adults aged 45 to 75 years. Since this patient is 72 and his last normal colonoscopy was 10 years ago, he is due for repeat screening. Conversely, the USPSTF recommends against prostate-specific antigen (PSA) screening for prostate cancer in men aged 70 years and older (Grade D) because the potential harms of screening outweigh the benefits in this age group.

Adım Adım Çözüm

1
Determine the patient's eligibility for colorectal cancer screening.
The patient is 72 years old and is 10 years out from his last normal colonoscopy. He is due for screening.
USPSTF guidelines recommend routine screening for colorectal cancer in all adults aged 45 to 75 years.
2
Determine the patient's eligibility for prostate cancer screening.
The patient is 72 years old, so PSA testing should be discouraged.
USPSTF recommends against PSA-based screening for prostate cancer in men aged 70 years and older (Grade D).
3
Evaluate the need for other risk-specific screenings based on history.
The patient has never smoked.
Screenings for abdominal aortic aneurysm (AAA) and lung cancer require a significant smoking history, which this patient lacks.

Anahtar Kavram

Age-appropriate cancer screening guidelines and upper-age cutoffs (USPSTF)
Soru 2043Soru →

A 52-year-old woman establishes care at a primary care clinic for a comprehensive wellness evaluation. She has a past medical history of essential hypertension that is well controlled on amlodipine. She currently smokes half a pack of cigarettes daily and has a 15-pack-year smoking history. She has no history of intravenous drug use, blood transfusions, or high-risk sexual behavior. A review of her lifelong medical records reveals that she has never undergone screening for hepatitis C. Her last screening colonoscopy at age 45 was normal. A screening mammogram performed 6 months ago was normal. Cervical cytology with high-risk human papillomavirus (hrHPV) co-testing was performed 3 years ago and was negative. She received a tetanus, diphtheria, and acellular pertussis (Tdap) booster 4 years ago and had an influenza vaccine last month. Physical examination is unremarkable. Her body mass index is 26 kg/m². Based on current guidelines, which of the following preventive interventions are indicated for this patient during today's visit? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Recombinant zoster vaccination; Hepatitis C virus antibody testing

Cevap

The indicated interventions are the recombinant zoster vaccination and Hepatitis C virus antibody testing.
Based on current guidelines, the recombinant zoster vaccination and Hepatitis C virus antibody testing are both indicated for this patient today. The Advisory Committee on Immunization Practices (ACIP) recommends the two-dose recombinant zoster vaccine for all immunocompetent adults starting at age 50, regardless of prior herpes zoster episodes. Additionally, the United States Preventive Services Task Force (USPSTF) recommends a one-time screening for hepatitis C virus (HCV) infection in all asymptomatic adults aged 18 to 79 years, superseding the older birth-cohort (baby boomer) recommendation. Since this 52-year-old patient has never been screened, HCV antibody testing is appropriate.

Adım Adım Çözüm

1
Evaluate the patient's age and vaccination history for adult immunizations.
The patient is 52 years old, making her eligible for the recombinant zoster vaccine, which starts at age 50.
Vaccination schedules dictate age-based milestones independent of chronic disease status.
2
Assess the need for infectious disease screening based on age and history.
The patient has no specific risk factors for Hepatitis C but is between 18 and 79 years old and has never been screened.
Current guidelines recommend one-time universal screening for HCV for all adults in this age group.
3
Calculate the smoking pack-year history to determine lung cancer screening eligibility.
The patient has a 15-pack-year history, which falls below the 20-pack-year threshold.
Guidelines explicitly require at least 20 pack-years for annual low-dose CT screening.
4
Review the intervals for previously completed age-appropriate screenings (cervical, breast, colorectal).
Cervical co-testing was done 3 years ago (due every 5), colonoscopy at 45 (due at 55), and mammogram 6 months ago (due every 1-2 years).
Routine screening intervals should not be shortened without specific clinical indications.

Anahtar Kavram

Application of age-based and risk-based preventive screening and immunization guidelines for middle-aged adults.
Soru 2044Soru →

A 58-year-old woman is brought to the emergency department by her family due to increased confusion and severe abdominal pain over the past 24 hours. She has a history of decompensated alcoholic cirrhosis and was recently discharged after treatment for esophageal varices. Her home medications include lactulose, rifaximin, spironolactone, furosemide, and propranolol.

Temperature is 38.4°C (101.1°F), blood pressure is 86/54 mmHg, pulse is 114/min, and respirations are 22/min. Physical examination reveals scleral icterus, spider angiomas, and a markedly distended abdomen with a positive fluid wave. There is diffuse, severe abdominal tenderness to palpation without rebound or guarding. Asterixis is present.

Laboratory studies show:
Leukocyte count: 14,500/μL14,500/\mu L
Platelet count: 88,000/μL88,000/\mu L
Serum sodium: 132 mEq/L132 \text{ mEq/L}
Serum potassium: 5.3 mEq/L5.3 \text{ mEq/L}
Serum creatinine: 2.1 mg/dL2.1 \text{ mg/dL} (baseline 1.0 mg/dL1.0 \text{ mg/dL})
Blood urea nitrogen: 52 mg/dL52 \text{ mg/dL}

Diagnostic paracentesis yields turbid ascitic fluid with a total nucleated cell count of 1,200/μL1,200/\mu L and 85%85\% neutrophils (1,020 PMNs/μL1,020 \text{ PMNs}/\mu L).

Which of the following pharmacologic interventions are indicated for this patient? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Initiate intravenous cefotaxime; Administer intravenous albumin; Discontinue home propranolol

Cevap

The correct interventions are to initiate intravenous cefotaxime, administer intravenous albumin, and discontinue home propranolol.
The patient's clinical presentation and ascitic fluid neutrophil count (1,020 PMNs/μL1,020 \text{ PMNs}/\mu L) confirm the diagnosis of spontaneous bacterial peritonitis (SBP), which is further complicated by an acute kidney injury (AKI) and hypotension. Optimal pharmacologic management requires three simultaneous interventions. First, empiric antimicrobial therapy must be initiated with a third-generation cephalosporin (e.g., intravenous cefotaxime) to adequately cover the most common causative organisms, including Escherichia coli, Klebsiella pneumoniae, and Streptococcus species. Second, intravenous albumin should be administered because it significantly reduces the incidence of hepatorenal syndrome and improves mortality in patients with SBP, especially those with baseline renal impairment (creatinine >1.0 mg/dL> 1.0 \text{ mg/dL} or BUN >30 mg/dL> 30 \text{ mg/dL}). Finally, rigorous medication reconciliation is critical: non-selective beta-blockers (propranolol) must be discontinued in cirrhotic patients who develop hypotension, AKI, or SBP. Beta-blockers inhibit the necessary compensatory increase in cardiac output during stress and are associated with increased mortality in this precise setting.

Adım Adım Çözüm

1
Evaluate the clinical presentation and paracentesis results.
Ascitic fluid with >250 PMNs/microL confirms the diagnosis of spontaneous bacterial peritonitis (SBP).
To establish the primary infectious diagnosis driving the patient's decompensation.
2
Evaluate the patient's renal function and hemodynamics.
The patient has an acute kidney injury (creatinine increased from 1.0 to 2.1 mg/dL) and systemic hypotension.
SBP frequently triggers hepatorenal syndrome and profound vasodilation, requiring specific adjunctive therapies and critical medication adjustments.
3
Select appropriate empiric antimicrobial therapy.
Initiate an intravenous third-generation cephalosporin such as cefotaxime.
Third-generation cephalosporins are first-line for community-acquired SBP to adequately cover enteric gram-negative rods and streptococci.
4
Determine necessary adjunctive therapies based on end-organ parameters.
Administer intravenous albumin.
Albumin expansion prevents hepatorenal syndrome and improves overall survival in SBP, with an absolute indication for patients with a BUN >30 mg/dL or creatinine >1.0 mg/dL.
5
Perform immediate medication reconciliation.
Discontinue home propranolol, spironolactone, and furosemide.
Beta-blockers blunt compensatory cardiac output during hypotensive stress in cirrhosis, thereby increasing mortality. Diuretics directly worsen volume depletion and acute kidney injury.

Anahtar Kavram

Simultaneous medical management of spontaneous bacterial peritonitis (SBP) involves empiric third-generation cephalosporins, intravenous albumin to prevent hepatorenal syndrome, and the immediate discontinuation of hemodynamically detrimental home medications such as non-selective beta-blockers and diuretics.
Soru 2045Soru →

During a routine medication management visit, a 52-year-old man reports a three-day history of worsening nausea, diarrhea, and unsteadiness. He was diagnosed with bipolar I disorder five years ago and has maintained psychiatric stability on a regimen of lithium carbonate. Two weeks prior to this visit, his primary care provider initiated hydrochlorothiazide for newly diagnosed primary hypertension. His temperature is 37.1°C (98.8°F), blood pressure is 122/78 mmHg, and pulse is 86/min. Neurological examination reveals a prominent coarse tremor in both hands and mild ataxia during tandem gait. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Withhold lithium and obtain a stat serum lithium level

Cevap

The most appropriate next step is to withhold lithium and obtain a stat serum lithium level.
The correct management is to withhold lithium and obtain a stat serum lithium level. This patient is exhibiting classic signs of acute-on-chronic lithium toxicity (nausea, diarrhea, coarse tremor, ataxia), precipitated by the recent addition of hydrochlorothiazide. Thiazide diuretics decrease renal lithium clearance by inducing volume depletion, which stimulates compensatory proximal tubular reabsorption of sodium and lithium. The immediate next step in evaluating and modifying this treatment regimen is to withhold the offending agent to prevent further accumulation and obtain a serum level to confirm the diagnosis and guide subsequent management (e.g., intravenous hydration, possible hemodialysis).

Adım Adım Çözüm

1
Identify the patient's acute clinical syndrome.
The patient presents with new-onset gastrointestinal symptoms (nausea, diarrhea), a coarse tremor, and ataxia.
These are classic systemic and neurological signs of lithium toxicity, which differ from the benign fine tremor seen at therapeutic levels.
2
Determine the precipitating cause of the syndrome.
The recent addition of hydrochlorothiazide (a thiazide diuretic).
Thiazide diuretics induce volume depletion, which stimulates compensatory proximal tubular reabsorption of both sodium and lithium, leading to toxic systemic accumulation of lithium.
3
Select the safest immediate intervention for treatment evaluation.
Withhold the lithium and measure serum lithium levels.
Further lithium administration is contraindicated during active toxicity. A serum level is required to confirm the diagnosis and determine the need for advanced therapies such as intravenous hydration or hemodialysis.

Anahtar Kavram

Initiation of thiazide diuretics in patients taking lithium decreases renal clearance of lithium, precipitating acute-on-chronic toxicity characterized by gastrointestinal distress, coarse tremors, and ataxia. Management requires immediate withholding of lithium and measuring serum levels.
Tahmini Süre:1m 15s
Soru 2046Soru →

A 65-year-old woman is brought to the emergency department after a witnessed generalized tonic-clonic seizure. Her family reports she has been feeling progressively lethargic and confused over the past 3 days while recovering from a severe gastrointestinal illness. Initial laboratory evaluation reveals a serum sodium level of 112 mEq/L. She is diagnosed with severe symptomatic hyponatremia. Arrange the following management and monitoring steps in the correct chronological sequence, from initial emergency intervention to ongoing maintenance.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence involves immediate administration of 3% hypertonic saline to treat the seizure, followed by a rapid recheck of the sodium level at 20 minutes. Once symptoms resolve and sodium has increased by a safe margin of 4-6 mEq/L, the hypertonic saline is stopped. Management then transitions to cause-specific therapy, followed by ongoing monitoring every 6 to 8 hours to prevent overcorrection and osmotic demyelination syndrome.
Severe symptomatic hyponatremia requires a carefully phased approach to management and monitoring. The initial objective is to rapidly reverse life-threatening cerebral edema using a bolus of 3% hypertonic saline, followed by an immediate 20-minute sodium recheck to confirm the expected 1-2 mEq/L rise. Once the patient's acute symptoms (such as seizures) resolve and the sodium level has risen by a safe threshold of 4-6 mEq/L, the emergency phase is effectively complete. At this point, hypertonic saline must be discontinued to avoid rapid overcorrection. The management focus then shifts to cause-specific therapy directed at the underlying pathophysiology. Finally, less frequent but vigilant monitoring (every 6 to 8 hours) is instituted to ensure the 24-hour correction limit of 8 mEq/L is strictly maintained, which is critical for preventing osmotic demyelination syndrome.

Adım Adım Çözüm

1
Administer an initial 100-150 mL bolus of 3% hypertonic saline intravenously.
The hypertonic load begins to draw fluid out of the brain tissue.
To rapidly reverse life-threatening cerebral edema and stop the seizure activity.
2
Recheck the serum sodium concentration and reassess neurological status 20 minutes after the infusion.
The physician confirms whether the sodium has appropriately risen by 1-2 mEq/L.
To evaluate the immediate clinical response and determine if an additional hypertonic bolus is required.
3
Discontinue hypertonic saline once acute neurological symptoms resolve and sodium increases by 4-6 mEq/L.
The acute phase of therapy is safely terminated.
To prevent accidental overcorrection once the brain is out of immediate danger.
4
Transition to cause-specific therapy such as fluid restriction or isotonic fluids.
The patient begins maintenance therapy directed at the primary volume status and etiology.
To address the root cause of the hyponatremia now that the neurological emergency is stabilized.
5
Continue monitoring serum sodium every 6 to 8 hours to ensure 24-hour correction does not exceed 8 mEq/L.
The rate of sodium correction is strictly controlled over the subsequent days.
To prevent osmotic demyelination syndrome caused by excessively rapid sodium correction.

Anahtar Kavram

Monitoring and adjusting the rate of sodium correction in severe symptomatic hyponatremia
Soru 2047Soru →

A 7474-year-old man is evaluated on the inpatient medical ward for acute agitation. He was admitted 22 days ago for a complicated urinary tract infection and has been receiving intravenous ceftriaxone. His medical history is significant for Parkinson disease, for which he takes carbidopa-levodopa, and benign prostatic hyperplasia. Temperature is 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F}), blood pressure is 134/82 mmHg134/82\text{ mmHg}, pulse is 88/min88/\text{min}, and respiratory rate is 16/min16/\text{min}. The nursing staff reports that the patient was awake most of the night, shouting at "strangers in the room" and repeatedly attempting to pull out his peripheral intravenous catheter. On examination, the patient is disoriented to time and place, and his attention fluctuates during the interview. He has a baseline resting tremor and upper extremity cogwheel rigidity. Non-pharmacologic interventions, including frequent reorientation, optimizing room lighting, and placing a dedicated sitter in the room, have failed to calm the patient, and he remains highly combative. Which of the following is the most appropriate pharmacologic intervention to manage this patient's acute agitation?

Cevabı ve açıklamayı göster

Cevap: Administer oral quetiapine

Cevap

Administer oral quetiapine.
The correct answer is to administer oral quetiapine. This patient is experiencing hyperactive delirium secondary to a urinary tract infection. While non-pharmacologic measures are the first-line treatment for delirium, pharmacologic intervention is indicated when the patient's agitation poses a direct threat to their safety or essential medical care (e.g., pulling out intravenous lines). In the general population, low-dose haloperidol is frequently used for severe delirium-associated agitation. However, in patients with Parkinson disease, typical antipsychotics (like haloperidol) and most atypical antipsychotics (like risperidone or olanzapine) are strictly contraindicated due to their strong dopamine (D2) receptor antagonism, which can precipitate severe extrapyramidal symptoms, profound rigidity, or an akinetic crisis. Quetiapine is the antipsychotic of choice for acute agitation in Parkinson disease because it has a very low affinity for D2 receptors and rapidly dissociates from them, providing sedative and antipsychotic effects without significantly worsening parkinsonian motor symptoms.

Adım Adım Çözüm

1
Diagnose the acute condition.
The patient is experiencing delirium, characterized by fluctuating attention, disorientation, and visual hallucinations, precipitated by a urinary tract infection.
Recognizing the underlying acute process is necessary before attempting symptomatic management.
2
Determine the indication for pharmacologic intervention.
Pharmacologic management is indicated because non-pharmacologic measures (sitter, reorientation) have failed, and the patient poses an immediate danger to his medical care (pulling out IV lines).
Antipsychotics in elderly patients with delirium should be reserved only for severe agitation that poses a safety risk.
3
Identify contraindications based on the patient's comorbidities.
The patient has Parkinson disease. Typical antipsychotics (like haloperidol) and most atypical antipsychotics (like risperidone) block dopamine (D2) receptors powerfully and will severely worsen his parkinsonism.
Avoiding medications that directly antagonize the depleted neurotransmitter system in Parkinson disease prevents catastrophic motor deterioration.
4
Select the safest pharmacologic agent.
Quetiapine is selected.
Quetiapine (along with clozapine and pimavanserin) has very low affinity for D2 receptors and rapid dissociation, making it the preferred agent for acute agitation or psychosis in patients with Parkinson disease.

Anahtar Kavram

In patients with Parkinson disease who develop severe, medically refractory delirium or psychosis, low-potency atypical antipsychotics with minimal D2 receptor affinity (such as quetiapine) are the preferred pharmacologic interventions to avoid precipitating an akinetic crisis.
Tahmini Süre:1m 30s
Soru 2048Soru →

A 6868-year-old man presents to an urgent care clinic with an expanding, warm, and erythematous rash on his left lower extremity. He has a medical history significant for a mechanical mitral valve replacement performed four years ago, for which he takes daily warfarin. His most recent International Normalized Ratio (INR) was 3.13.1 two days ago (target range 2.52.5 to 3.53.5). The physician diagnoses purulent cellulitis and prescribes a 77-day course of oral trimethoprim-sulfamethoxazole. Which of the following actions are the most appropriate next steps in the management of this patient's anticoagulation? (Select 2 answers)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Pre-emptively reduce the weekly dose of warfarin by 25%25\% to 50%50\%; Schedule a follow-up International Normalized Ratio (INR) test in 33 to 55 days

Cevap

The correct management includes pre-emptively reducing the weekly dose of warfarin by 25%25\% to 50%50\% and scheduling a follow-up INR test in 33 to 55 days.
Trimethoprim-sulfamethoxazole strongly inhibits the cytochrome P450 2C9 (CYP2C9) isoenzyme, which is responsible for clearing the more potent S-enantiomer of warfarin. Additionally, the antibiotic eliminates intestinal flora that produce vitamin K, further intensifying the anticoagulant effect. When initiating this specific antibiotic in a patient stabilized on warfarin, standard medical guidelines mandate an immediate, pre-emptive dose reduction of the warfarin by 25%25\% to 50%50\%. Because the interaction takes time to alter the steady-state degradation of coagulation factors (particularly Factor II), the International Normalized Ratio (INR) must be closely monitored and rechecked within 33 to 55 days to ensure the patient remains within the target therapeutic window and to guide any further necessary dosing adjustments.

Adım Adım Çözüm

1
Identify the pharmacokinetic interaction between the patient's baseline medication (warfarin) and the newly prescribed medication (trimethoprim-sulfamethoxazole).
Trimethoprim-sulfamethoxazole is a potent inhibitor of the cytochrome P450 2C9 (CYP2C9) enzyme.
CYP2C9 metabolizes the highly active S-enantiomer of warfarin. Inhibition leads to decreased clearance, accumulating levels, and elevated INR.
2
Determine the necessary treatment modification to mitigate the interaction risk.
The warfarin dose must be empirically reduced by 25%25\% to 50%50\%.
Without pre-emptive reduction, the patient is at profound risk for hemorrhagic complications due to the prolonged half-life of the active drug.
3
Establish the correct monitoring parameter and appropriate time interval for re-evaluation.
Order an INR test in 33 to 55 days.
It takes several days for the alteration in factor synthesis to be reflected in the INR. Checking it at 33 to 55 days detects the peak effect of the interaction and allows for further safe titration.

Anahtar Kavram

Monitoring and dose adjustment for pharmacokinetic interactions with high-risk anticoagulants.
Soru 2049Soru →

A 55-year-old man is brought to the emergency department via ambulance for severe shortness of breath, facial swelling, and a diffuse rash. His symptoms began 15 minutes ago while eating at a seafood restaurant. His medical history is significant for hypertension, hyperlipidemia, and a prior myocardial infarction. His home medications include metoprolol, atorvastatin, and aspirin. On physical examination, the patient is in severe respiratory distress with prominent stridor, accessory muscle use, and diffuse expiratory wheezing. Widespread urticaria is noted on his trunk and extremities. Vitals are temperature 37.1°C (98.8°F), blood pressure 72/40 mm Hg, pulse 62/min, and respiratory rate 28/min. Intravenous access is rapidly established by the nursing staff.

Arrange the following pharmacologic interventions in the most appropriate sequential order for the stepwise resuscitation and management of this patient, from the immediate life-saving therapy to the final adjunctive treatment.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence of interventions is: 1) Administer intramuscular epinephrine, 2) Administer rapid intravenous normal saline bolus, 3) Administer intravenous glucagon, and 4) Administer intravenous methylprednisolone.
The correct sequence adheres to the standard stepwise protocol for acute anaphylaxis resuscitation. Intramuscular epinephrine is the universal first step to halt the allergic cascade and support hemodynamics. Because anaphylaxis is a severe distributive shock state, intravascular volume depletion must be rapidly corrected next with isotonic crystalloids. If the patient remains unstable, it is critical to recognize that his home metoprolol is blocking the beta-adrenergic effects of epinephrine, indicated by his lack of compensatory tachycardia (pulse 62/min). Therefore, glucagon must be administered as a targeted rescue agent because it bypasses the beta-receptor to increase intracellular cAMP. Finally, intravenous methylprednisolone is administered as an adjunctive measure to prevent a delayed biphasic reaction; it has no role in acute hemodynamic stabilization.

Adım Adım Çözüm

1
Administer intramuscular epinephrine.
Stimulates alpha-1, beta-1, and beta-2 receptors.
This is the unequivocal first-line, life-saving therapy for anaphylaxis. It must be administered immediately to reverse vasodilation, support blood pressure, and cause bronchodilation.
2
Administer rapid intravenous normal saline bolus.
Replenishes depleted intravascular volume.
Anaphylaxis causes severe distributive shock with massive capillary leak. Isotonic crystalloids are the standard fundamental resuscitation step initiated concurrently with or immediately following epinephrine.
3
Administer intravenous glucagon.
Activates adenylate cyclase independently of the beta-adrenergic receptor to increase intracellular cAMP.
The patient's pulse is 62/min despite profound shock, indicating that his home metoprolol is blunting the compensatory tachycardia and the efficacy of epinephrine. Glucagon is the specific escalation therapy for refractory anaphylaxis in beta-blocked patients.
4
Administer intravenous methylprednisolone.
Downregulates the late-phase systemic inflammatory response.
Corticosteroids play no role in the immediate reversal of acute anaphylactic shock. They are given as an adjunctive, final step to reduce the risk of a biphasic reaction hours later.

Anahtar Kavram

Stepwise escalation of pharmacologic therapy in anaphylactic shock, specifically addressing the management of epinephrine-refractory shock in patients taking beta-blockers.
Tahmini Süre:2m 0s
Soru 2050Soru →

An outpatient clinic evaluates a 42-year-old man who is returning for a scheduled visit. Four weeks ago, he was diagnosed with active pulmonary tuberculosis and was started on a standard daily regimen of isoniazid, rifampin, pyrazinamide, and ethambutol. Today, the patient reports significant improvement in his initial respiratory symptoms. He states he has a good appetite and explicitly denies fatigue, nausea, vomiting, abdominal pain, dark-colored urine, or generalized pruritus. His vital signs are within normal limits. Physical examination reveals a non-tender, non-distended abdomen with no palpable hepatomegaly, and there is no evidence of scleral icterus.

Routine laboratory studies obtained earlier today reveal the following:

Laboratory TestResultReference Range
Alanine aminotransferase (ALT)175 U/L10-40 U/L
Aspartate aminotransferase (AST)160 U/L10-40 U/L
Alkaline phosphatase90 U/L40-120 U/L
Total bilirubin0.8 mg/dL0.1-1.2 mg/dL

Which of the following is the most appropriate next step in the management of this patient's therapy?

Cevabı ve açıklamayı göster

Cevap: Continue the current regimen and repeat the liver function panel in one week

Cevap

The most appropriate step is to continue the current regimen and repeat the liver function panel in one week.
The correct action is to continue the current treatment regimen and monitor the liver function closely. Isoniazid, rifampin, and pyrazinamide are known to cause drug-induced liver injury. However, mild asymptomatic transaminase elevations (up to 20% of patients) often reflect transient hepatic adaptation. Established guidelines mandate the discontinuation of these medications only if the AST/ALT levels exceed 3 times the upper limit of normal (ULN) in the presence of hepatitis symptoms (e.g., nausea, vomiting, abdominal pain, jaundice) OR if the levels exceed 5 times the ULN in the absence of symptoms. This patient is asymptomatic and his levels are approximately 4 to 4.5 times the ULN; therefore, he has not met the criteria for discontinuation. Close surveillance is the optimal management strategy.

Adım Adım Çözüm

1
Analyze the patient's symptoms and timeline.
The patient is completely asymptomatic 4 weeks into standard anti-tuberculosis therapy.
Presence or absence of symptoms (like nausea, fatigue, right upper quadrant pain) is a major branching point in hepatotoxicity algorithms.
2
Evaluate the laboratory abnormalities.
ALT is 175 U/L and AST is 160 U/L. The upper limit of normal (ULN) is 40 U/L, meaning these values are approximately 4 to 4.5 times the ULN. Bilirubin and alkaline phosphatase are normal.
Quantifying the exact elevation relative to the ULN is required to apply toxicity guidelines.
3
Apply clinical monitoring guidelines for tuberculosis drug-induced liver injury.
Guidelines recommend discontinuing hepatotoxic TB drugs only if transaminases are >3 times the ULN with accompanying symptoms, or >5 times the ULN regardless of symptoms.
Following evidence-based thresholds prevents the premature cessation of life-saving antibiotics while still protecting the patient from severe liver failure.
4
Determine the necessary intervention.
Since the patient is asymptomatic and his liver enzymes are <5 times the ULN, the therapy should be maintained and labs should be monitored closely (e.g., in 1 week).
Mild to moderate asymptomatic elevations often represent transient hepatic adaptation and usually resolve without intervention.

Anahtar Kavram

Monitoring thresholds for Anti-Tuberculosis drug-induced hepatotoxicity
Soru 2051Soru →

A 60-year-old female is evaluated in the primary care clinic for the management of elevated blood pressure. Over the past three clinic visits, her blood pressure has consistently averaged 154/96154/96 mmHg. Her past medical history is significant for bipolar I disorder, which has been well controlled on lithium carbonate for the past eight years without mood instability. She also has moderate persistent asthma, managed with a daily inhaled corticosteroid and as-needed albuterol. Her current vital signs are: heart rate 7878/min, respiratory rate 1414/min, and blood pressure 152/94152/94 mmHg. Physical examination is unremarkable, with clear lungs bilaterally and a regular heart rhythm. Recent laboratory studies reveal a serum creatinine of 0.90.9 mg/dL, serum potassium of 4.14.1 mEq/L, and a serum lithium level of 0.80.8 mEq/L (therapeutic range: 0.6−1.20.6-1.2 mEq/L). The physician decides to initiate pharmacologic monotherapy for essential hypertension. Which of the following is the most appropriate pharmacologic intervention for this patient?

Cevabı ve açıklamayı göster

Cevap: Amlodipine

Cevap

Amlodipine is the most appropriate first-line antihypertensive for this patient, as it safely lowers blood pressure without interacting with her chronic lithium therapy or exacerbating her asthma.
Amlodipine is a dihydropyridine calcium channel blocker and a first-line agent for the treatment of essential hypertension. In a patient with concurrent bipolar disorder on lithium and asthma, it is the safest choice because it does not significantly alter the renal clearance of lithium, nor does it affect bronchial smooth muscle tone. It effectively lowers blood pressure without exacerbating her underlying airway disease or precipitating neurologic toxicity from lithium accumulation.

Adım Adım Çözüm

1
Identify the primary clinical objective
The patient requires initiation of a first-line antihypertensive medication for newly diagnosed essential hypertension.
Blood pressure measurements have consistently remained elevated across multiple visits, indicating a need for pharmacotherapy.
2
Analyze the patient's comorbidities for therapeutic constraints
The patient has bipolar I disorder currently managed with lithium, and moderate persistent asthma.
Comorbidities heavily dictate the safety profile required for new prescriptions, especially to avoid drug-drug interactions or disease exacerbations.
3
Evaluate first-line antihypertensive classes against the patient's lithium use
Thiazide diuretics, ACE inhibitors, and ARBs must be excluded.
These three classes decrease renal clearance of lithium by promoting its reabsorption in the proximal tubule, leading to a high risk of lithium toxicity (e.g., ataxia, tremors, encephalopathy).
4
Evaluate remaining antihypertensive options against the patient's asthma
Non-selective beta-blockers must be excluded.
Medications that block beta-2 receptors can trigger severe bronchospasm in patients with reactive airway disease.
5
Select the optimal agent
Amlodipine (a calcium channel blocker) is chosen.
It is a first-line antihypertensive that effectively lowers blood pressure, does not significantly alter lithium clearance, and is safe in asthma.

Anahtar Kavram

Patients taking lithium require careful selection of concurrent medications; thiazide diuretics, ACE inhibitors, NSAIDs, and ARBs significantly reduce renal lithium clearance and can rapidly precipitate toxicity. Calcium channel blockers are generally safe alternatives for managing hypertension in these patients.
Soru 2052Soru →

Match each patient's clinical profile with the most appropriate next step in preventive care screening based on current United States Preventive Services Task Force (USPSTF) guidelines.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

62-year-old male, current smoker with a 30 pack-year history. All other routine preventive screenings are up to date.
68-year-old female, never-smoker. She had a normal dual-energy x-ray absorptiometry (DEXA) scan 3 years ago and a normal screening colonoscopy 10 years ago.
24-year-old female, sexually active with a new partner. She had a normal cervical cytology (Pap smear) 2 years ago.
42-year-old male, non-smoker with a body mass index of 31 kg/m². All other routine preventive screenings are up to date.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The 62-year-old male matches Annual LDCT; the 68-year-old female matches Screening colonoscopy; the 24-year-old female matches Genitourinary NAAT; the 42-year-old male matches Screening for abnormal blood glucose.
Each patient's clinical profile aligns perfectly with a specific, strongly recommended (Grade A or B) USPSTF screening intervention based on their age, sex, BMI, sexual activity, and smoking history.

Adım Adım Çözüm

1
Evaluate the 62-year-old male's clinical profile.
He meets criteria for lung cancer screening (age 50-80, ≥20 pack-year history).
USPSTF guidelines mandate annual LDCT for this demographic.
2
Assess the 68-year-old female's medical history.
Her last colonoscopy was 10 years ago, making her due for a repeat exam.
Average-risk adults aged 45-75 should undergo colonoscopy every 10 years.
3
Analyze the 24-year-old female's age and sexual history.
She is under 25 and sexually active, requiring STI screening. Her Pap smear is up to date.
Annual chlamydia and gonorrhea screening is indicated for sexually active women < 25 years.
4
Review the 42-year-old male's demographic data.
He is overweight (BMI ≥ 25) and falls into the 35-70 age range.
These factors necessitate screening for prediabetes and type 2 diabetes.

Anahtar Kavram

Age-appropriate and risk-based preventive screening guidelines
Tahmini Süre:1m 30s
Soru 2053Soru →

A 67-year-old man comes to the clinic for a routine wellness examination. His past medical history includes essential hypertension, hyperlipidemia, and osteoarthritis. He underwent a normal screening colonoscopy at age 65 and had a negative hepatitis C antibody test last year. He reports smoking a pack of cigarettes per day from age 18 to 22 but has not smoked since. He drinks alcohol occasionally. Current medications are lisinopril, atorvastatin, and as-needed ibuprofen. Blood pressure is 128/78 mm Hg, and pulse is 72/min. Cardiopulmonary examination is unremarkable, and abdominal examination reveals no pulsatile masses. Which of the following is the most appropriate next step in preventive care for this patient?

Cevabı ve açıklamayı göster

Cevap: One-time abdominal ultrasonography

Cevap

One-time abdominal ultrasonography
The recommendation for abdominal ultrasonography is correct because the patient fits the exact criteria established by the United States Preventive Services Task Force (USPSTF) for abdominal aortic aneurysm screening. Men between the ages of 65 and 75 who have smoked at least 100 cigarettes in their lifetime should receive a one-time screening ultrasound to evaluate for the presence of an abdominal aortic aneurysm. This patient's 4 pack-year history easily meets the 'ever smoked' threshold.

Adım Adım Çözüm

1
Identify the patient's demographic and risk factor profile.
The patient is a 67-year-old male with a history of smoking (4 pack-years).
Age, sex, and smoking history dictate eligibility for specific USPSTF preventive screening guidelines.
2
Determine if the patient meets the 'ever smoked' threshold.
The patient smoked 1 pack a day for 4 years (approximately 29,200 cigarettes), which far exceeds the 100 lifetime cigarettes threshold.
The definition of 'ever smoked' in the context of abdominal aortic aneurysm screening is at least 100 cigarettes in a lifetime.
3
Apply the appropriate screening guideline for this demographic.
The patient is a man aged 65 to 75 who has 'ever smoked', making him eligible for a one-time screening for an abdominal aortic aneurysm.
The USPSTF assigns a Grade B recommendation for one-time ultrasound screening for AAA in men aged 65 to 75 years who have ever smoked.

Anahtar Kavram

Abdominal Aortic Aneurysm (AAA) Screening Guidelines
Soru 2054Soru →

During a post-discharge follow-up visit, a physician evaluates a 6565-year-old male who was hospitalized three weeks ago for an anterior ST-elevation myocardial infarction complicated by acute decompensated heart failure. He currently performs activities of daily living independently but notes mild shortness of breath when walking up a slight incline. His medical history includes hypertension, type 2 diabetes mellitus, and a severe episode of oropharyngeal swelling that required emergency intubation shortly after initiating lisinopril three years ago.

Current medications include aspirin, clopidogrel, atorvastatin, and furosemide as needed.

Vital signs show a blood pressure of 122/78122/78 mmHg, a heart rate of 7070/min, and a respiratory rate of 1616/min. Physical examination reveals no jugular venous distention, clear lungs on auscultation, and no peripheral edema. A recent echocardiogram demonstrates a left ventricular ejection fraction of 30%30\%.

Laboratory results:
- Serum sodium: 138138 mEq/L
- Serum potassium: 4.34.3 mEq/L
- Serum creatinine: 1.11.1 mg/dL
- Estimated glomerular filtration rate: 6868 mL/min/1.73 m21.73 \text{ m}^2

Which of the following pharmacologic interventions are indicated to improve this patient's long-term survival? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Oral metoprolol succinate; Oral dapagliflozin; Oral spironolactone

Cevap

The indicated interventions are oral metoprolol succinate, oral dapagliflozin, and oral spironolactone.
The correct combination of therapies includes a cardioselective beta-blocker, an SGLT2 inhibitor, and a mineralocorticoid receptor antagonist. These three drug classes are foundational elements of guideline-directed medical therapy for heart failure with reduced ejection fraction, providing proven mortality and hospitalization benefits. The patient has appropriate blood pressure, heart rate, potassium levels, and renal function to initiate all three simultaneously.

Adım Adım Çözüm

1
Identify the primary clinical condition and patient status.
The patient has heart failure with reduced ejection fraction (HFrEF) with an ejection fraction of 30% and NYHA Class II symptoms following a recent myocardial infarction.
Establishing the functional class and left ventricular function determines which therapeutic guidelines apply.
2
Determine the pillars of guideline-directed medical therapy (GDMT) for HFrEF.
Standard GDMT requires a beta-blocker, a renin-angiotensin system inhibitor (preferably an ARNI), a mineralocorticoid receptor antagonist (MRA), and an SGLT2 inhibitor.
These four classes provide additive mortality and morbidity benefits in HFrEF.
3
Evaluate the patient's medical history for contraindications to GDMT components.
The patient has a history of severe angioedema from lisinopril (an ACE inhibitor).
A history of ACE inhibitor-induced angioedema is an absolute contraindication to the use of any ACE inhibitor or ARNI (sacubitril-valsartan).
4
Select the appropriate, safe medications from the available options.
Metoprolol succinate, dapagliflozin, and spironolactone are indicated and safe. Sacubitril-valsartan is contraindicated due to allergy. Verapamil is contraindicated due to its negative inotropic effect.
This establishes a comprehensive, safe, and guideline-concordant regimen that avoids critical errors.

Anahtar Kavram

Guideline-directed medical therapy for HFrEF includes four main pillars, but absolute contraindications (such as a history of ACE inhibitor-induced angioedema precluding the use of an ARNI) must be rigorously identified and avoided.
Tahmini Süre:1m 30s
Soru 2055Soru →

A 6262-year-old woman is evaluated in the hospital on postoperative day 6 following a total right knee arthroplasty. Since the surgery, she has been receiving prophylactic subcutaneous unfractionated heparin. Her postoperative course has been otherwise uncomplicated. Today, she reports new-onset swelling and dull pain in her right calf. Vital signs are temperature 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F}), blood pressure 128/82128/82 mmHg, pulse 8888/min, and respirations 1616/min. Physical examination reveals pitting edema and tenderness in the right lower extremity.

Laboratory TestResult
Platelet count95,000/mm395,000/\text{mm}^3
Preoperative platelet count260,000/mm3260,000/\text{mm}^3
Hemoglobin11.211.2 g/dL
Leukocyte count7,500/mm37,500/\text{mm}^3

A lower extremity venous duplex ultrasound is performed and confirms a new acute deep vein thrombosis in the right popliteal vein.

Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Discontinue unfractionated heparin and initiate argatroban

Cevap

The most appropriate next step is to discontinue unfractionated heparin and initiate argatroban.
The correct action is to discontinue unfractionated heparin and initiate argatroban. This patient's presentation—a >50%>50\% decline in platelet count occurring 5 to 10 days after starting unfractionated heparin, coupled with a new venous thrombosis—is highly specific for heparin-induced thrombocytopenia (HIT) type 2. HIT is an immune-mediated disorder caused by IgG antibodies targeting complexes of heparin and platelet factor 4 (PF4). These antibodies activate platelets, creating a profoundly hypercoagulable state. The cornerstone of HIT management is the immediate cessation of all forms of heparin (including flushes) and the prompt initiation of a non-heparin anticoagulant. Direct thrombin inhibitors (e.g., argatroban, bivalirudin) or fondaparinux are the preferred agents.

Adım Adım Çözüm

1
Evaluate the timeline and laboratory changes in relation to the medication regimen.
The patient developed a greater than 50%50\% drop in her platelet count on postoperative day 6 after exposure to unfractionated heparin.
This specific timing and degree of thrombocytopenia are the classic hallmarks of heparin-induced thrombocytopenia (HIT) type 2.
2
Assess the new clinical findings alongside the laboratory data.
The patient has a newly confirmed deep vein thrombosis, classifying her condition as HIT with thrombosis (HITT).
HIT is a highly prothrombotic state. The formation of a new clot while on prophylactic heparin confirms therapeutic failure and immune-mediated platelet activation.
3
Determine the necessary treatment evaluation and modification.
All heparin products must be immediately discontinued, and an alternative, non-heparin anticoagulant (such as argatroban or fondaparinux) must be initiated.
Continued exposure to any form of heparin will fuel the immune response, leading to life-threatening thrombotic complications such as pulmonary embolism or limb gangrene.

Anahtar Kavram

Patients who develop a >50%>50\% drop in platelet count and new thrombosis within 5-10 days of heparin exposure have heparin-induced thrombocytopenia (HIT). Management requires immediately stopping all heparin products and initiating a non-heparin anticoagulant like argatroban or fondaparinux.
Soru 2056Soru →

During a comprehensive health review, a 58-year-old female patient provides her medical history to her new primary care clinician. Her past medical diagnoses include type 2 diabetes mellitus, which is well-controlled on metformin, and a prior hepatitis C infection that was cured with direct-acting antivirals. She had a negative fourth-generation HIV test during her previous hepatitis C workup. She currently feels well and has no acute symptoms. The patient's substance use history is notable for a 25-pack-year smoking habit; however, she emphasizes that she achieved complete cessation 13 years ago. Review of her preventive care documentation reveals a normal screening colonoscopy six years ago and negative cervical cytology with human papillomavirus co-testing three years ago. Her most recent bilateral mammogram was performed two months ago and showed no abnormalities. She received a 20-valent pneumococcal conjugate vaccine upon her diabetes diagnosis and had her seasonal influenza vaccine two weeks ago. Vital signs and physical examination are unremarkable today. Based on current preventive guidelines, which of the following is the most appropriate next step in screening for this patient?

Cevabı ve açıklamayı göster

Cevap: Non-contrast low-dose computed tomography of the chest

Cevap

Non-contrast low-dose computed tomography of the chest
This patient meets the United States Preventive Services Task Force (USPSTF) criteria for annual lung cancer screening with non-contrast low-dose computed tomography of the chest. The guidelines recommend screening for adults aged 50 to 80 years who have a 20 pack-year or greater smoking history and who currently smoke or have quit within the past 15 years. Because this 58-year-old patient has a 25-pack-year history and achieved complete cessation 13 years ago, she is within the 15-year window and requires this screening.

Adım Adım Çözüm

1
Evaluate the patient's smoking history against lung cancer screening criteria.
The patient has a 25-pack-year history and quit 13 years ago.
Guidelines recommend annual screening for adults aged 50 to 80 with a 20 pack-year or greater smoking history who currently smoke or quit within the past 15 years.
2
Assess the need for colon, cervical, and breast cancer screening based on her previous test dates.
None of these are currently due. Colonoscopy is due in 4 years, Pap/HPV co-testing in 2 years, and mammogram is up to date.
Applying standard screening intervals prevents overutilization of medical tests.
3
Determine indications for bone density and abdominal aortic aneurysm screening.
Neither test is indicated for this patient.
Bone density screening routinely begins at age 65 for women, and abdominal aortic aneurysm screening is not a standard recommendation for women.

Anahtar Kavram

Lung cancer screening criteria require annual low-dose chest computed tomography for adults aged 50 to 80 years with a 20 pack-year smoking history who currently smoke or have quit within the past 15 years.
Tahmini Süre:1m 30s
Soru 2057Soru →

A 7272-year-old man is being evaluated in the intensive care unit for liberation from mechanical ventilation. He was admitted 99 days ago for acute respiratory distress syndrome secondary to severe influenza A pneumonia. His initial airway management was complicated, requiring three intubation attempts using video laryngoscopy. Today, his condition has markedly improved; he is hemodynamically stable off vasopressor support, and arterial blood gas analysis reveals a PaO 2_2 of 8585 mm Hg on a fraction of inspired oxygen (FiO 2_2) of 0.300.30 and a positive end-expiratory pressure (PEEP) of 55 cm H 2_2 O. The critical care team plans to systematically de-escalate his respiratory support. Arrange the following monitoring and therapeutic de-escalation steps in the most appropriate chronological sequence to safely liberate this patient from mechanical ventilation.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The most appropriate sequence is: spontaneous awakening trial, followed by a spontaneous breathing trial, confirmation of adequate gas exchange, an endotracheal tube cuff leak test, and finally extubation.
Safe liberation from mechanical ventilation follows a standardized, chronological sequence. First, continuous sedatives must be interrupted (Spontaneous Awakening Trial) to allow the patient to demonstrate a normal respiratory drive and appropriate mental status. Second, a Spontaneous Breathing Trial (SBT) is initiated using minimal support to test the patient's ability to maintain the work of breathing. Third, objective physiological data, such as an arterial blood gas, are obtained toward the end of the SBT to verify adequate gas exchange. Fourth, because this patient is at high risk for laryngeal edema due to a prolonged (greater than 6 days) and traumatic intubation, a cuff leak test is specifically indicated to predict post-extubation stridor. Finally, if the cuff leak test is reassuring, the endotracheal tube is removed, and the patient is monitored closely for any signs of respiratory failure.

Adım Adım Çözüm

1
Perform a spontaneous awakening trial (SAT).
The patient regains consciousness and demonstrates a spontaneous respiratory effort.
Sedatives suppress respiratory drive and mask neurologic baseline; they must be paused to accurately assess the patient's capacity to breathe.
2
Initiate a spontaneous breathing trial (SBT).
The patient breathes independently with minimal pressure support.
Simulates post-extubation cardiopulmonary conditions to ensure the patient has sufficient reserve to breathe without the ventilator.
3
Assess objective gas exchange parameters.
Arterial blood gas confirms adequate oxygenation and absence of severe hypercapnia.
Provides objective physiological confirmation that the patient has successfully passed the SBT before planning removal of the tube.
4
Perform a cuff leak test.
An adequate air leak is detected when the endotracheal cuff is deflated.
To evaluate for laryngeal edema. This is strongly indicated in patients at high risk for airway narrowing due to prolonged (greater than 6 days) or traumatic intubations.
5
Extubate the patient.
The endotracheal tube is safely removed.
The final step in the de-escalation protocol once all safety, mechanical, and physiological criteria for liberation are met.

Anahtar Kavram

The systematic sequence for liberating a patient from mechanical ventilation involves paired awakening and breathing trials, followed by risk stratification for post-extubation airway complications prior to extubation.
Tahmini Süre:1m 0s
Soru 2058Soru →

Based on the provided demographic and clinical risk profiles, match each patient with the single most appropriate guideline-concordant preventive screening modality.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 68-year-old male with a history of essential hypertension who smoked a pack of cigarettes daily from age 20 to 45.
A 42-year-old asymptomatic female with no significant family history of malignancy seeking routine health maintenance.
A 54-year-old male with a 25 pack-year smoking history who quit 10 years ago and has a chronic morning cough.
A 66-year-old female with a body mass index of 22 kg/m² presenting for an annual wellness visit with no new complaints.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The 68-year-old former smoker matches with abdominal ultrasonography. The 42-year-old female matches with biennial mammography. The 54-year-old recent quitter matches with annual low-dose computed tomography. The 66-year-old female matches with dual-energy x-ray absorptiometry.
Each correct pairing directly applies the most current USPSTF recommendations regarding the specific age cutoffs, sex differences, and historical risk factors (such as smoking duration and cessation timing) that dictate the next best step in preventive care.

Adım Adım Çözüm

1
Evaluate the 68-year-old male's smoking history and age.
Identified age 65-75 and a history of having smoked at least 100 cigarettes (25 pack-years, quit 23 years ago).
To confirm indication for one-time abdominal aortic aneurysm screening and rule out lung cancer screening due to quitting more than 15 years ago.
2
Assess the 42-year-old female's age relative to updated cancer screening guidelines.
Identified age over 40.
To apply the updated USPSTF recommendation for biennial mammography starting universally at age 40.
3
Analyze the 54-year-old male's pack-year history and years since quitting.
Identified 25 pack-years and quit 10 years ago.
To confirm indication for annual low-dose chest computed tomography, as he meets the age criteria (50-80), pack-year criteria (>=20), and quit duration criteria (<=15 years).
4
Review the 66-year-old female's age and general risk profile.
Identified female age 65 or older.
To confirm the standard indication for routine bone mineral density screening without the need for additional risk calculation tools.

Anahtar Kavram

Age, sex, and risk-factor specific preventive screening based on USPSTF guidelines.
Tahmini Süre:1m 30s
Soru 2059Soru →

A 55-year-old woman is evaluated in the cardiology clinic for follow-up of heart failure with reduced ejection fraction. She reports persistent fatigue and dyspnea when walking up a single flight of stairs. Her current medications include maximum tolerated doses of sacubitril-valsartan, bisoprolol, and dapagliflozin. Blood pressure is 118/76 mmHg and heart rate is 68/min. A recent echocardiogram showed a left ventricular ejection fraction of 30%. The physician decides to add spironolactone to her regimen to improve her long-term outcomes. Which of the following diagnostic tests must be obtained 1 to 2 weeks after initiating this medication? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Serum potassium; Serum creatinine

Cevap

Serum potassium and serum creatinine
The correct options are serum potassium and serum creatinine. Spironolactone is a mineralocorticoid receptor antagonist (MRA) that serves as a critical component of guideline-directed medical therapy for heart failure with reduced ejection fraction. By blocking aldosterone at the distal convoluted tubule and collecting duct, it promotes sodium excretion and potassium retention. Because this patient is already taking an angiotensin receptor-neprilysin inhibitor (sacubitril-valsartan), which also decreases aldosterone secretion and promotes potassium retention, she is at a significantly elevated risk for hyperkalemia. Furthermore, MRAs can cause acute renal impairment. Therefore, clinical guidelines strictly mandate checking both serum potassium and renal function (serum creatinine) 1 to 2 weeks after the initiation or dose escalation of an MRA.

Adım Adım Çözüm

1
Analyze the patient's current diagnosis and medication regimen.
The patient has HFrEF and is taking sacubitril-valsartan, bisoprolol, dapagliflozin, and is starting spironolactone.
Identifying the pharmacologic classes is necessary to predict drug-drug interactions and adverse effects.
2
Identify the mechanism and primary side effects of the newly added medication.
Spironolactone is a mineralocorticoid receptor antagonist (potassium-sparing diuretic) that can cause hyperkalemia and renal dysfunction.
Understanding the adverse effect profile dictates the required safety monitoring.
3
Evaluate the additive risks from the patient's baseline regimen.
The patient is taking sacubitril-valsartan (an ARNI), which also promotes potassium retention, significantly increasing the risk of hyperkalemia.
Concurrent use of multiple renin-angiotensin-aldosterone system inhibitors compounds the risk of adverse events.
4
Select the guideline-directed monitoring parameters for this clinical scenario.
Guidelines mandate checking serum potassium and serum creatinine 1 to 2 weeks after initiating a mineralocorticoid receptor antagonist.
Early detection of hyperkalemia and acute kidney injury is essential to prevent life-threatening arrhythmias and renal failure.

Anahtar Kavram

Initiation of a mineralocorticoid receptor antagonist (like spironolactone) requires close monitoring of serum potassium and renal function (creatinine) within 1 to 2 weeks, especially in patients concurrently taking other RAAS inhibitors.
Soru 2060Soru →

A 47-year-old man presents to the clinic to establish primary care. He has not visited a healthcare provider in over a decade and feels well, with no acute symptoms or concerns. He takes no medications. He has smoked 1 pack of cigarettes daily since age 20. He consumes 1 or 2 alcoholic beverages on the weekends. Family history is notable for a father who died of a myocardial infarction at age 75. Vital signs include a blood pressure of 126/82 mm Hg, heart rate of 74/min, and a body mass index of 27 kg/m². Physical examination is unremarkable. Which of the following is the most appropriate next step in screening for this patient?

Cevabı ve açıklamayı göster

Cevap: Fecal immunochemical testing

Cevap

Fecal immunochemical testing
The correct answer is fecal immunochemical testing. The United States Preventive Services Task Force (USPSTF) recommends colorectal cancer screening for all adults aged 45 to 75 years. Because this patient is 47 years old and has not seen a physician in ten years, he is due for baseline screening. Fecal immunochemical testing is an appropriate first-line, non-invasive screening modality.

Adım Adım Çözüm

1
Evaluate the patient's demographic profile and risk factors.
The patient is a 47-year-old man with a 27 pack-year smoking history, body mass index of 27 kg/m², and no other significant specific risk factors for early-onset diseases.
Preventive screening guidelines are heavily dependent on age, biological sex, and specific risk factors such as smoking history.
2
Determine indications for colorectal cancer screening.
Current guidelines recommend initiating colorectal cancer screening at age 45 for average-risk adults.
The patient is 47 years old and has not had any preventive care in a decade, making him due for baseline colorectal cancer screening via modalities such as fecal immunochemical testing or colonoscopy.
3
Assess whether the patient meets criteria for other specific screenings listed in the options.
He does not meet the age threshold for lung cancer screening (begins at 50), abdominal aortic aneurysm screening (begins at 65), or prostate cancer screening discussion (begins at 55).
Applying the correct age cutoffs is essential to avoid over-screening and unnecessary downstream testing.

Anahtar Kavram

Colorectal cancer screening should be initiated at age 45 for average-risk adults. Age cutoffs are strict for interventions like lung cancer and abdominal aortic aneurysm screening.
ÖncekiSayfa 103 / 104Sonraki
Patient Management Alıştırma Soruları — USMLE Step 3 — Sayfa 103 | Examkin